BridgeMD
New treatment option for Acute Respiratory Distress Syndrome
Official title Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis
ClinicalTrials.gov ID: NCT07439848
What this study is testing
What is UC-MSC?
UC-MSC is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for acute respiratory distress syndrome.
Also referred to as Umbilical Cord- Mesenchymal Stem Cell (UC-MSC).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study was conducted to determine the effect of Umbilical Cord Mesenchymal Stem Cell (UC-MSC) and Secretome in severe ARDS patients. The study is a randomized control trial - double blind, which has 3 arms intervention namely, Control treatment, UC-MSC treatment, and UC-MSC and Secretome treatment.
- Phase 2: a mid-size study of how well it works
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 and older
You may be able to join if
- Male or female at least 40 years old when the Informed Consent Form (ICF) is signed by the family, as evidenced by an identity card.
- Patients with severe ARDS according to Berlin criteria
- Families are willing to participate in clinical trial procedures including not participating in other clinical trials for the duration of...
You likely can't join if
- A pregnant woman is proven by a pregnancy test.
- The results of the SGOT or SGPT examination increased \> 5 times the upper limit of the normal laboratory value in the hospital.
- Estimated glomerular filtration rate (eGFR) \< 30 ml/min, including patients undergoing routine hemodialysis.
- Having more than 2 of the following co-morbidities; hypertension, diabetes, chronic heart disease, chronic lung disease, COPD, asthma, tuberculosis...
- The results of the lipid profile are far above normal (what is the cut off number?). Normal cholesterol levels for women aged 20 years and over are...
- PT APTT, C Peptide
The study team makes the final eligibility decision.
Where it's taking place
- Jakarta Pusat, DKI Jakarta, Indonesia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Jakarta Pusat, DKI Jakarta, Indonesia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.